Sequana Medical
Last verified 2026-05-07. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $108.0Mattributed |
|---|---|
| Latest round | seed, $25.9M, 2025-03-01attributed |
| Founded | 2008 |
| Headquarters | Ghent, Belgium |
| Industry | healthtech |
| Stage | series-b+ |
| Website | sequana.com |
Sequana Medical develops implantable systems to treat drug-resistant fluid overload in liver disease, heart failure, and cancer. It serves patients with conditions like recurrent ascites from cirrhosis and their clinicians. Its FDA-approved alfapump automatically moves built-up abdominal fluid into the bladder for natural elimination.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-03-01 | seed | $25.9M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Seed, $25.9M | attributed | sifted named as publisher. No document URL on file. |
| Total raised $108.0M | attributed | sifted named as publisher. No document URL on file. |
| Company existence | self-reported | sequana.com, read 2026-05-07 |
| Description | self-reported | sequana.com, read 2026-05-07 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.